A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies
Authors:
- 22 March 2022
- journal article
- research article
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 72 (05) , 255-258
Abstract
A recombinant vector vaccine TB/FLU-04L for the prevention of tuberculosis was developed in RIBSP CS MES RK and SRII. The vaccine is based on the attenuated influenza strain Flu NS106/ESAT-6_Ag85A expressing mycobacterial antigens Esat-6 and Ag85A. This research aimed to conduct pre-clinical safety studies of the vaccine as one of the basic and mandatory stages in the development and introduction of immunobiological preparations. The studies were performed at the research centers of the Republic of Kazakhstan and the Russian Federation. The experiment was conducted on ferrets, monkeys, and rabbits. The TB/FLU-04L vaccine was administered intranasally (7.5 lg TCID50/animal). The clinical signs, body weight, temperature, hematological parameters, and local irritant effects were monitored throughout the study. The results of the study demonstrated the safety of the TB/FLU-04L intranasal vector vaccine against tuberculosis since its administration in laboratory animals led to no adverse effects in any of the monitored parameters. No influenza A virus particles were isolated from samples of nasal washes. Received: 28 December 2021 Accepted: 28 February 2022 Publication Date: 22 March 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
This publication has 7 references indexed in Scilit:
- Novel vaccine candidates against Mycobacterium tuberculosisInternational Journal of Biological Macromolecules, 2018
- Animal models used to assess influenza antiviralsExpert Opinion on Drug Discovery, 2018
- New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural ImmunityTrends in Immunology, 2018
- The ongoing story of the Bacille Calmette–Guérin (BCG) vaccinationActa Paediatrica, 2016
- Sleeping Beauty and the Story of the Bacille Calmette-Guérin VaccinemBio, 2016
- Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosisTuberculosis, 2012
- Mucosal immunity and vaccinesNature Medicine, 2005